Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Eyepoint Pharmaceuticals, Inc. (EYPT) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Eyepoint Pharmaceuticals, Inc. (EYPT) lobbying for?
Summary of lobbying data:
– Eyepoint Pharmaceuticals, Inc. hired two lobbying firms: Hogan Lovells Us Llp and Forbes-Tate.
– They lobbied on general issues such as Budget/Appropriations, Medicare/Medicaid, and Health Issues.
– Specific issues they lobbied on include improving patient access for advanced ophthalmic products, biopharmaceutical innovation and reimbursement incentives, and H.R. 5376 – Inflation Reduction Act of 2022 (P.L. 117-169).
РThey also lobbied on general healthcare issues as well as issues related to H.R. 925 – The Heroes Act.
– The government agencies they lobbied were Senate, Department of Health & Human Services (HHS), and House of Representatives.
One could infer that Eyepoint Pharmaceuticals, Inc. is lobbying on these issues to advocate for favorable policies that support their goal of bringing advanced ophthalmic products to market and improving patient access to them. They may also be lobbying for incentives to encourage biopharmaceutical innovation and reimbursement policies that benefit their company. Additionally, their lobbying on the Heroes Act suggests they are interested in policies related to COVID-19 relief and economic stimulus, which could benefit their business.
